FDA 483 - Emergent Biodefense Operations Lansing LLC - November 05, 2013

An FDA inspection of Emergent BioDefense Operations Lansing, LLC in Lansing, MI, revealed numerous deficiencies across its manufacturing and quality systems. Key issues include inadequate environmental monitoring, unvalidated QC methods, insufficient material storage controls, and a lack of adherence to and formalization of standard operating procedures. These findings indicate a need for comprehensive corrective actions to ensure product quality and regulatory compliance.